Physician profile
Amy Decker
NPI 1144839861
$960.54
in general payments reported to CMS, 2019-2025
26 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $513 · 2022: $242 · 2023: $21.88 · 2024: $14.45 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $205.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $172.46 | 2021-2022 | |
| Incyte Corporation | $135.82 | 2021-2022 | |
| Celgene Corporation | $101.69 | 2021 | |
| Novartis Pharmaceuticals Corporation | $53.71 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $48.02 | 2021-2025 | Lynparza |
| Genentech USA, INC. | $42.12 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $37.36 | 2021 | |
| Janssen Biotech, INC. | $34.14 | 2021-2025 | Tecvayli, Darzalex, Carvykti |
| Organogenesis INC. | $33.40 | 2025 | Via Matrix |
| Alexion Pharmaceuticals, INC. | $32.66 | 2021 | |
| Genzyme Corporation | $23.88 | 2021 | |
| Kci USA, INC. | $21.88 | 2023 | Prevena, V.A.C.Ulta |
| Octapharma USA, INC. | $21.09 | 2022 | |
| Caris Mpi, INC. | $20.39 | 2025 | Mi Cancer Seek |
| Puma Biotechnology, INC. | $18.42 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dova Pharmaceuticals | $17.83 | 2021 | |
| G1 Therapeutics, INC. | $16.98 | 2022 | |
| Sobi, INC | $16.16 | 2025 | |
| Taiho Oncology, INC. | $15.38 | 2022 | |
| Jazz Pharmaceuticals INC. | $15.03 | 2025 | |
| Abbvie INC. | $14.45 | 2024 | |
| Novocure INC. | $14.29 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.91 | 2021 | |
| Glaxosmithkline, LLC. | $13.46 | 2025 | Ojjaara, Blenrep |
| Rigel Pharmaceuticals, INC. | $13.24 | 2022 | |
| Pfizer INC. | $12.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Decker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.